Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Cash & Equivalents (2016 - 2025)

iRhythm Holdings (IRTC) has disclosed Cash & Equivalents for 11 consecutive years, with $236.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 43.75% to $236.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $236.0 million, a 43.75% decrease, with the full-year FY2025 number at $236.0 million, down 43.75% from a year prior.
  • Cash & Equivalents was $236.0 million for Q4 2025 at iRhythm Holdings, down from $255.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $550.6 million in Q2 2024 to a low of $36.2 million in Q4 2023.
  • A 5-year average of $222.9 million and a median of $111.8 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 1059.97% in 2024, then tumbled 61.05% in 2025.
  • iRhythm Holdings' Cash & Equivalents stood at $110.1 million in 2021, then dropped by 28.42% to $78.8 million in 2022, then plummeted by 54.11% to $36.2 million in 2023, then skyrocketed by 1059.97% to $419.6 million in 2024, then tumbled by 43.75% to $236.0 million in 2025.
  • Per Business Quant, the three most recent readings for IRTC's Cash & Equivalents are $236.0 million (Q4 2025), $255.6 million (Q3 2025), and $214.4 million (Q2 2025).